Evidence map›Paper›PMID 28145532›Full record

ArticleScientific reports2017

Computational imaging reveals shape differences between normal and malignant prostates on MRI.

Mirabela Rusu, Andrei S Purysko, Sadhna Verma, Jonathan Kiechle, Jay Gollamudi, Soumya Ghose, Karin Herrmann, Vikas Gulani, Raj Paspulati, Lee Ponsky and 8 more

Abstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Hypoxia Imaging as a Radiomics Signature in Tumors Using NovelbioRxiv : the preprint server for biology · 2025
    Article
  2. Article
  3. Observational
  4. Article
  5. Article
  6. Article
  7. Novel Quantitative Imaging for Predicting Response to Therapy: Techniques and Clinical Applications.American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting · 2018
    Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Mirabela RusuDepartment of Biomedical Engineering, Case Western Reserve University, 10900 Euclid Avenue, Cleveland, Ohio, 44106, USA.
Andrei S PuryskoSection of Abdominal Imaging and Nuclear Radiology Department, Imaging Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland OH 44195, USA.
Sadhna VermaUniversity of Cincinnati Medical Center, 234 Goodman Street, Cincinnati, Ohio, 45267, USA.
Jonathan KiechleUniversity Hospitals Cleveland Medical Center and Case Western Reserve University, 11100 Euclid Avenue, Cleveland, Ohio, 44106, USA.
Jay GollamudiUniversity of Cincinnati Medical Center, 234 Goodman Street, Cincinnati, Ohio, 45267, USA.
Soumya GhoseDepartment of Biomedical Engineering, Case Western Reserve University, 10900 Euclid Avenue, Cleveland, Ohio, 44106, USA.
Karin HerrmannUniversity Hospitals Cleveland Medical Center and Case Western Reserve University, 11100 Euclid Avenue, Cleveland, Ohio, 44106, USA.
Vikas GulaniUniversity Hospitals Cleveland Medical Center and Case Western Reserve University, 11100 Euclid Avenue, Cleveland, Ohio, 44106, USA.
Raj PaspulatiUniversity Hospitals Cleveland Medical Center and Case Western Reserve University, 11100 Euclid Avenue, Cleveland, Ohio, 44106, USA.
Lee PonskyUniversity Hospitals Cleveland Medical Center and Case Western Reserve University, 11100 Euclid Avenue, Cleveland, Ohio, 44106, USA.
Maret BöhmGarvan Institute of Medical Research, The Kinghorn Cancer Centre, 384 Victoria St, Darlinghurst, New South Wales, 2010, Australia.
Anne-Maree HaynesGarvan Institute of Medical Research, The Kinghorn Cancer Centre, 384 Victoria St, Darlinghurst, New South Wales, 2010, Australia.
Daniel MosesRadiology Department, Spectrum Medical Imaging, 13-15 Silver St, Randwick, New South Wales, 2031, Australia.
Ron ShnierSouthern Radiology, Neuroscience Research Australia, Barker St &Easy St, Randwick, New South Wales, 2031, Australia.
Warick DelpradoDouglass Hanly Moir Pathology, 14 Giffnock Ave, Macquarie Park, New South Wales, 2113, Australia.
James ThompsonGarvan Institute of Medical Research, The Kinghorn Cancer Centre, 384 Victoria St, Darlinghurst, New South Wales, 2010, Australia.
Phillip StrickerSt. Vincent's Prostate Cancer Center, 390 Victoria St, Darlinghurst, New South Wales, 2010, Australia.
Anant MadabhushiDepartment of Biomedical Engineering, Case Western Reserve University, 10900 Euclid Avenue, Cleveland, Ohio, 44106, USA.

Funding

Computerized histologic image predictor of cancer outcomeR01CA202752 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI FELDMAN, MICHAEL D, GANESAN, SHRIDAR · 2016 to 2020
$3.1M
Pathology Image Informatics Platform for visualization, analysis and managementU24CA199374 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI GURCAN, METIN NAFI, MADABHUSHI, ANANT · 2015 to 2019
$2.9M
Comprehensive quantitative ultrafast 3D liver MRIR01DK098503 · NIDDK · CASE WESTERN RESERVE UNIVERSITY · PI GULANI, VIKAS, SEIBERLICH, NICOLE · 2013 to 2017
$2.6M
Decision support with MRI for targeting, evaluating laser ablation for prostate cR21CA167811 · NCI · RUTGERS, THE STATE UNIV OF N.J. · PI MADABHUSHI, ANANT · 2012 to 2013
$516k
Histologic image-based aggressiveness prediction in p16+ oropharyngeal carcinomaR21CA179327 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI MADABHUSHI, ANANT · 2014 to 2015
$389k
Computerized morphologic-molecular predictor of progression in DCISR21CA195152 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI BADVE, SUNIL S., MADABHUSHI, ANANT · 2015 to 2016
$388k
NCI NIH HHS R01 CA202752NCI NIH HHS R21 CA167811NCI NIH HHS R21 CA179327NCI NIH HHS R21 CA195152NCI NIH HHS U24 CA199374NIDDK NIH HHS R01 DK098503
6 · The paper itself

Abstract

We seek to characterize differences in the shape of the prostate and the central gland (combined central and transitional zones) between men with biopsy confirmed prostate cancer and men who were identified as not having prostate cancer either on account of a negative biopsy or had pelvic imaging done for a non-prostate malignancy. T2w MRI from 70 men were acquired at three institutions. The cancer positive group (PCa+) comprised 35 biopsy positive (Bx+) subjects from three institutions (Gleason scores: 6-9, Stage: T1-T3). The negative group (PCa-) combined 24 biopsy negative (Bx-) from two institutions and 11 subjects diagnosed with rectal cancer but with no clinical or MRI indications of prostate cancer (Cl-). The boundaries of the prostate and central gland were delineated on T2w MRI by two expert raters and were used to construct statistical shape atlases for the PCa+, Bx- and Cl- prostates. An atlas comparison was performed via per-voxel statistical tests to localize shape differences (significance assessed at p < 0.05). The atlas comparison revealed central gland hypertrophy in the Bx- subpopulation, resulting in significant volume and posterior side shape differences relative to PCa+ group. Significant differences in the corresponding prostate shapes were noted at the apex when comparing the Cl- and PCa+ prostates.

Indexed as

Imaging, Three-DimensionalMagnetic Resonance ImagingHumansMaleOrgan SizeProstateProstatic Neoplasms

Identifiers

PMID28145532
PMCPMC5286513

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.